Live feed
Filing
SC 13G
SC 13G0001104659-22-050817·Lincoln Park Capital Fund, LLC
Schedule 13G ownership disclosure
Salarius Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 79400X107
Event date: 2022-04-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,969,718
- Percent of class
- 5.9800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-050817
- Form type
- SC 13G
- Filer
- Lincoln Park Capital Fund, LLC
- CIK
- CIK 1592644
- Filed
- Apr 27, 2022
- Reporting period
- Apr 22, 2022
- Description
- Schedule 13G beneficial ownership